Evidence map›Paper›PMID 40548847›Full record

ArticleOrganic letters2025

Biosynthesis of Circumdatins Employs an Anthranilate Tailoring Pathway for NRPS Substrate Supplies.

Yura Sato, Yohei Morishita, Yuto Homma, Akihiro Sugawara, Ashaimaa Y Moussa, Ahmed M Elissawy, Abdel Nasser B Singab, Taro Ozaki, Teigo Asai

Abstract read
In one paragraph

Article in Organic letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yura SatoGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
Yohei MorishitaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.ORCID 0000-0001-8442-8642
Yuto HommaGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.
Akihiro SugawaraGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.ORCID 0000-0003-1266-7497
Ashaimaa Y MoussaDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt.ORCID 0000-0001-7818-3319
Ahmed M ElissawyDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt.
Abdel Nasser B SingabDepartment of Pharmacognosy, Faculty of Pharmacy, Ain-Shams University, Cairo 11566, Egypt.ORCID 0000-0001-7445-963X
Taro OzakiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.ORCID 0000-0002-4673-4478
Teigo AsaiGraduate School of Pharmaceutical Sciences, Tohoku University, Sendai 980-8578, Japan.ORCID 0000-0002-8903-392X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circumdatins are a unique class of fungal alkaloids featuring a pyrrolo[4,2]benzodiazepine scaffold. In this study, we identified the biosynthetic gene cluster through genome mining guided by structural analysis and docking simulations. Heterologous expression and precursor feeding experiments revealed an unprecedented tailoring pathway in which anthranilate is modified to yield 5-methoxyanthranilate (5-MA), a substrate for nonribosomal peptide synthetase. This work highlights a unique adenylation domain with substrate promiscuity capable of recognizing both anthranilate and 5-MA.

Indexed as

AlkaloidsBenzodiazepinonesortho-AminobenzoatesPeptide SynthasesMolecular StructureMultigene FamilySubstrate SpecificityAlkaloidsanthranilic acidBenzodiazepinonesnon-ribosomal peptide synthaseortho-AminobenzoatesPeptide Synthases

Identifiers

PMID40548847
PMCPMC12235696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.